Source disclosure: January 30, 2026
DAIKEN MEDICAL CO.,LTD. [7775.T]
TOKYO, Feb 17 (Pulse News Wire) – Daiken Medical Co., Ltd. (7775.T) reported consolidated results for Q3 FY2026 (ending March 2026).
88 billion (+2.8% YoY). 11 billion (-15.2%). net profit attributable to shareholders was ¥840 million (-12.2%).
1 billion with an equity ratio of 69.0%. For the next fiscal year, the company forecasts 2 billion (+2.5%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms • Original filing💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.